Ventilator-associated Complications, Including Infection-related Complications. The Way Forward

Critical Care Clinics

Volumn 29, Issue 1, 2013, Pages 33-50

  Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ICU; Pneumonia; VAC; VAP

Indexed keywords

ARTIFICIAL VENTILATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; INFECTION PREVENTION; INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; CROSS INFECTION; EVIDENCE-BASED PRACTICE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, VENTILATOR-ASSOCIATED; QUALITY INDICATORS, HEALTH CARE; VENTILATORS, MECHANICAL;

EID: 84870219944     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.10.004     Document Type: Review

References (85)

1. Nguile-Makao M., Zahar J.R., Francais A., et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010, 36:781-789.
2. Shorr A.F., Zilberberg M.D., Kollef M. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2009, 30:759-763.
3. Warren D.K., Shukla S.J., Olsen M.A., et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003, 31:1312-1317.
4. Kollef M.H., Hamilton C.W., Ernst F.R. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012, 33:250-256.
5. Bekaert M., Timsit J.F., Vansteelandt S., et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011, 184:1133-1139.
6. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009, 360:439-443.
7. Chung R., Song J.-H., Kim S.H., et al. High prevalence of multidrug-resistant non-fermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011, 184:1409-1417.
8. Kallen A.J., Hidron A.I., Patel J., et al. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010, 31:528-531.
9. Vincent J.L., Rello J., Marshall J., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.
10. Kollef K.E., Schramm G.E., Wills A.R., et al. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 2008, 134:281-287.
11. Centers for Disease Control and Prevention (CDC) Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep 2010, 59:750.
12. Cantón R., Akóva M., Carmeli Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
13. Viau R.A., Hujer A.M., Marshall S.H., et al. "Silent" Dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in northeast Ohio. Clin Infect Dis 2012, 54:1314-1321.
14. Lee Y.T., Kuo S.C., Yang S.P., et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012, 55(2):209-215.
15. Sandiumenge A., Rello J. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 2012, 18:187-193.
16. Ferrer R., Artigas A., Suarez D., et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009, 180:861-866.
17. Boucher H., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
18. Kollef M.H. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008, 47:S3-S13.
19. Johnson M.T., Reichley R., Hoppe-Bauer J., et al. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011, 39:1859-1865.
20. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
21. Dhainaut J.F., Laterre P.F., LaRosa S.P., et al. The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results. Crit Care Med 2003, 31:2291-2301.
22. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31:2742-2751.
23. Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003, 115:529-535.
24. Halpern N.A., Hale K.E., Sepkowitz K.A., et al. A world without ventilator-associated pneumonia: time to abandon surveillance and deconstruct the bundle. Crit Care Med 2012, 40:267-270.
25. Kollef M.H. Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal. Crit Care Med 2012, 40:271-277.
26. Morrow L.E., Kollef M.H. Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010, 38:S352-S362.
27. Tejerina E., Esteban A., Fernandez-Segoviano P., et al. Accuracy of clinical definitions of ventilator-associated pneumonia: comparison of autopsy findings. J Crit Care 2010, 25:62-66.
28. Rea-Neto A., Youssef N.C., Tuche F., et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008, 12:R56.
29. Vincent J.L., de Souza Barros D., Cianferoni S. Diagnosis, management, and prevention of ventilator-associated pneumonia. Drugs 2010, 70:1927-1944.
30. Wunderink R.G., Woldenberg L.S., Zeiss J., et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992, 101:458-463.
31. Pingleton S.K., Fagon J.Y., Leeper K.V. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992, 102:553S-556S.
32. American Thoracic Society; Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 71:388-416.
33. Centers for Disease Control and Prevention: National Nosocomial Infections Surveillance System (NNIS). Available at: Accessed March 7, 2012. http://www.cdc.gov/ncidod/dhqp/nnis.html.
34. Miller P.R., Johnson J.C., Karchmer T., et al. National nosocomial infection surveillance system: from benchmark to bedside in trauma patients. J Trauma 2006, 60:98-103.
35. Skrupky L., McConnell K., Dallas J., et al. A comparison of ventilator-associated pneumonia rates as identified according to National Healthcare Safety Network (NHSN) and American College of Chest Physicians (ACCP) Criteria. Crit Care Med 2012, 40:281-284.
36. Klompas M. Is a ventilator-associated pneumonia rate of zero really possible?. Curr Opin Infect Dis 2012, 25:176-182.
37. Torres A., Fabregas N., Ewig S., et al. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references. Crit Care Med 2000, 28:2799-2804.
38. Balthazar A.B., Von N.A., De Capitani E.M., et al. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz J Med Biol Res 2001, 34:993-1001.
39. Torres A., el-Ebiary M., Padró L., et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994, 149:324-331.
40. Torres A., El-Ebiary M., Fábregas N., et al. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996, 51:378-384.
41. Kirtland S.H., Corley D.E., Winterbauer R.H., et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997, 112:445-457.
42. Marquette C.H., Copin M.C., Wallet F., et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995, 151:1878-1888.
43. Papazian L., Autillo-Touati A., Thomas P., et al. Diagnosis of ventilator-associated pneumonia: an evaluation of direct examination and presence of intracellular organisms. Anesthesiology 1997, 87:268-276.
44. Rouby J.J., Rossignon M.D., Nicolas M.H., et al. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989, 71:679-685.
45. Fàbregas N., Ewig S., Torres A., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54:867-873.
46. Riaz O.J., Malhotra A.K., Aboutanos M.B., et al. Bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia: to quantitate or not, that is the question. Am Surg 2011, 77:297-303.
47. Fagon J.Y., Chastre J., Wolff M., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000, 132:621-630.
48. Shorr A.F., Sherner J.H., Jackson W.L., et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005, 33:46-53.
49. Ibrahim E.H., Ward S., Sherman G., et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001, 29:1109-1115.
50. Dellit T.H., Chan J.D., Skerrett S.J., et al. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008, 29:525-533.
51. Bouadma L., Luyt C.E., Tubach F., et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474.
52. Stolz D., Smyrnios N., Eggimann P., et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009, 34:1364-1375.
53. Micek S.T., Ward S., Fraser V.J., et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799.
54. Singh N., Rogers P., Atwood C.W., et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
55. Klompas M., Khan Y., Kleinman K., et al. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011, 6:e18062.
56. Klompas M., Kleinman K., Khan Y., et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis 2012, 54:370-377.
57. Uçkay I., Ahmed Q.A., Sax H., et al. Ventilator-associated pneumonia as a quality indicator for patient safety?. Clin Infect Dis 2008, 46:557-563.
58. Magill S.S., Fridkin S.K. Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement. Clin Infect Dis 2012, 54:378-380.
59. Zack J.E., Garrison T., Trovillion E., et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002, 30:2407-2412.
60. Babcock H.M., Zack J.E., Garrison T., et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system. A comparison of effects. Chest 2004, 125:2224-2231.
61. Apisarnthanarak A., Pinitchai U., Thongphubeth K., et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis 2007, 45:704-711.
62. Lansford T., Moncure M., Carlton E., et al. Efficacy of a pneumonia prevention protocol in the reduction of ventilator-associated pneumonia in trauma patients. Surg Infect (Larchmt) 2007, 8:505-510.
63. Sona C.S., Zack J.E., Schallom M.E., et al. The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med 2009, 24:54-62.
64. Kollef M.H. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004, 32:1396-1405.
65. DuBose J.J., Inaba K., Shiflett A., et al. Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. J Trauma 2008, 64:22-27.
66. Wahl W.L., Talsma A., Dawson C., et al. Use of computerized ICU documentation to capture ICU core measures. Surgery 2006, 140:684-689.
67. Weiss C.H., Moazed F., McEvoy C.A., et al. Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. Am J Respir Crit Care Med 2011, 184:680-686.
68. Berenholtz S.M., Pham J.C., Thompson D.A., et al. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol 2011, 32:305-314.
69. Rello J., Afonso E., Lisboa T., et al. A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect 2012, [Epub ahead of print].
70. Bouadma L., Mourvillier B., Deiler V., et al. A multifaceted program to prevent ventilator-associated pneumonia: impact on compliance with preventive measures. Crit Care Med 2010, 38:789-796.
71. Pittet D., Zingg W. Reducing ventilator-associated pneumonia: when process control allows outcome improvement and even benchmarking. Crit Care Med 2010, 38:983-984.
72. Bouadma L., Deslandes E., Lolom I., et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010, 51:1115-1122.
73. Institute for healthcare improvement. Available at: Accessed June 3, 2011. http://www.ihi.org.
74. Zilberberg M.D., Shorr A.F., Kollef M.H. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med 2009, 37:305-309.
75. Kollef M.H., Afessa B., Anzueto A., et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 20(300):805-813.
76. Lorente L., Blot S., Rello J., et al. New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2010, 182:870-876.
77. Muscedere J., Rewa O., McKechnie K., et al. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med 2011, 39:1985-1991.
78. Heimes J., Braxton C., Nazir N., et al. Implementation and enforcement of ventilator-associated pneumonia prevention strategies in trauma patients. Surg Infect (Larchmt) 2011, 12:99-103.
79. Rosenthal V.D., Alvarez-Moreno C., Villamil-Gómez W., et al. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings. Am J Infect Control 2011, 40(6):497-501.
80. Al-Tawfiq J.A., Abed M.S. Decreasing ventilator-associated pneumonia in adult intensive care units using the Institute for Healthcare Improvement bundle. Am J Infect Control 2010, 38:552-556.
81. Morris A.C., Hay A.W., Swann D.G., et al. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med 2011, 39:2218-2224.
82. Ramirez P., Bassi G.L., Torres A. Measures to prevent nosocomial infections during mechanical ventilation. Curr Opin Crit Care 2012, 18:86-92.
83. Rewa O., Muscedere J. Ventilator-associated pneumonia: update on etiology, prevention, and management. Curr Infect Dis Rep 2011, 13:287-295.
84. Kollef M. SMART approaches for reducing nosocomial infections in the ICU. Chest 2008, 134:447-456.
85. Culig M.H., Kunkle R.F., Frndak D.C., et al. Improving patient care in cardiac surgery using Toyota production system based methodology. Ann Thorac Surg 2011, 91:394-399.